Acrivon Therapeutics Provides Clinical Data Updates for ACR-368 and Initial ACR-2316 Data

Acrivon Therapeutics, Inc.

On January 8, 2026, Acrivon hosted a webcast and conference call featuring ACR-368 clinical data and program updates.
Initial clinical data for ACR-2316 were presented during the webcast.
The presentation was posted on the company website at ir.acrivon.com under Investors & Media.
Exhibit 99.1 to the 8-K filing contains the January 8, 2026 Data Update.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.